Related references
Note: Only part of the references are listed.Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects
Kevin C. Kobylinski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial
Brian D. Foy et al.
LANCET (2019)
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial
Menno R. Smit et al.
LANCET INFECTIOUS DISEASES (2018)
A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
Alison Roth et al.
NATURE COMMUNICATIONS (2018)
Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi
Yudi T. Pinilla et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles
Kevin C. Kobylinski et al.
MALARIA JOURNAL (2017)
Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments
Haoues Alout et al.
MALARIA JOURNAL (2014)
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination
Carlos J. Chaccour et al.
MALARIA JOURNAL (2013)
Liquid chromatography-mass spectrometry based global metabolite profiling: A review
Georgios A. Theodoridis et al.
ANALYTICA CHIMICA ACTA (2012)
Current applications of high-resolution mass spectrometry in drug metabolism studies
Markus R. Meyer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Ivermectin in Human Medicine, An Overview of the Current Status of Its Clinical Applications
P. Gonzalez et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
The use of mass defect in modern mass spectrometry
Lekha Sleno
JOURNAL OF MASS SPECTROMETRY (2012)
Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae
Kevin C. Kobylinski et al.
MALARIA JOURNAL (2012)
It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS
Ragu Ramanathan et al.
JOURNAL OF MASS SPECTROMETRY (2011)
Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?
William Kudzi et al.
BMC MEDICAL GENETICS (2010)
Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry
Haiying Zhang et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Improving LC-MS sensitivity through increases in chromatographic performance: Comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS
MI Churchwell et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Share Paper
